# Situation: A 24-year-old woman with asthma is brought to the emergency room (ER) with wheezing and breathlessness that began after a viral cold. At home she uses only a salbutamol (albuterol) inhaler, about 6 to 8 times a week. She has no other illness, takes no other medicines, and her oxygen saturation by pulse oximetry (SpO2) is monitored continuously. After she recovers, the physician prescribes a budesonide–formoterol inhaler to be used whenever she has symptoms. She says, "My cousin has a salmeterol–fluticasone inhaler, and her doctor told her never to use it for quick relief. Why can I use mine that way?" Which explanation should the nurse give?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=629678  
> language: ko  
> subject: Nursing Practice III — Care of Clients with Problems in Surgery, Oxygenation, Fluid and Electrolytes, Infectious, Inflammatory and Immunologic Response, Cellular Aberrations

## 문제

Situation: A 24-year-old woman with asthma is brought to the emergency room (ER) with wheezing and breathlessness that began after a viral cold. At home she uses only a salbutamol (albuterol) inhaler, about 6 to 8 times a week. She has no other illness, takes no other medicines, and her oxygen saturation by pulse oximetry (SpO2) is monitored continuously.

After she recovers, the physician prescribes a budesonide–formoterol inhaler to be used whenever she has symptoms. She says, "My cousin has a salmeterol–fluticasone inhaler, and her doctor told her never to use it for quick relief. Why can I use mine that way?" Which explanation should the nurse give?

## 보기

1. Budesonide eases airway swelling within minutes, unlike other steroids
2. Formoterol starts working within minutes; salmeterol works slowly **✔ 정답**
3. Formoterol is short-acting like salbutamol; salmeterol is long-acting
4. Salmeterol only prevents attacks and cannot open the airways during one

**정답: 2**

## 해설

Formoterol and salmeterol are both long-acting beta2 agonists, but formoterol has a fast onset, so an inhaler that combines it with an inhaled corticosteroid can relieve symptoms within minutes while treating inflammation with each use. Salmeterol has a slow onset and is not used as a reliever. The inhaled corticosteroid in either inhaler acts on inflammation over days, not minutes.

## 심화 해설

Core pharmacologic distinction

The patient is asking why a budesonide–formoterol inhaler can serve as an as-needed reliever while a salmeterol–fluticasone inhaler cannot. The answer rests on the difference between the two long-acting beta2-agonists (LABAs): formoterol and salmeterol.

Both formoterol and salmeterol are classified as LABAs because their bronchodilator effect lasts approximately 12 hours. However, their onset of action differs substantially. Formoterol begins to relax airway smooth muscle within 1–3 minutes of inhalation, comparable to the short-acting beta2-agonist salbutamol. Salmeterol, by contrast, has a slow onset of roughly 15–30 minutes or longer, which makes it unsuitable for acute symptom relief. [1]

Why the corticosteroid component does not explain rapid relief

The patient’s cousin was told never to use salmeterol–fluticasone for quick relief. A common misunderstanding is that the inhaled corticosteroid (ICS) in either combination might provide fast symptom improvement. It does not. Inhaled corticosteroids such as budesonide and fluticasone work on airway inflammation over days to weeks, not within minutes. Therefore, the rapid-relief property of budesonide–formoterol comes entirely from the formoterol component, not from budesonide.

Anti-inflammatory reliever (AIR) therapy concept

Current asthma guidelines have moved away from relying on short-acting beta2-agonist (SABA)-only rescue therapy. The rationale is that symptom worsening before an exacerbation involves both bronchoconstriction and airway inflammation. Using a SABA alone treats only bronchoconstriction while leaving inflammation unaddressed. [1]

Anti-inflammatory reliever (AIR) therapy combines an ICS with a fast-onset bronchodilator in a single inhaler used as needed for symptom relief. The two currently available AIR combinations are:

| Combination | Bronchodilator onset | Role in AIR therapy |
| --- | --- | --- |
| Budesonide–formoterol | Fast (1–3 min) | As-needed reliever and controller |
| ICS–salbutamol (albuterol) | Fast (3–5 min) | As-needed reliever and controller |
| Salmeterol–fluticasone | Slow (15–30 min) | Maintenance only, not for acute relief |

The budesonide–formoterol combination is the most extensively studied AIR regimen, with randomized controlled trials demonstrating a substantial reduction in severe exacerbations when used as reliever therapy.

Why option 2 is correct and the others fail

Option 2 states that formoterol starts working within minutes while salmeterol works slowly. This directly addresses the pharmacologic basis for the different clinical roles of the two LABAs. [1]

Option 1 is incorrect because budesonide does not ease airway swelling within minutes; ICS effects on inflammation require days of regular use.

Option 3 is incorrect because it misclassifies formoterol as short-acting. Formoterol is a long-acting beta2-agonist with a fast onset; its duration of action is approximately 12 hours, which distinguishes it from salbutamol. [1]

Option 4 is incorrect because salmeterol can open the airways during an attack, but it does so too slowly to serve as a rescue medication. The issue is the speed of onset, not an absence of bronchodilator effect. [1]

Key point! The distinction between formoterol and salmeterol is not long-acting versus short-acting. Both are LABAs. The clinically meaningful difference is onset of action: formoterol is fast, salmeterol is slow. This single pharmacologic property determines whether a LABA-containing inhaler can be used as an as-needed reliever. [1]

Watch out! Do not equate the ICS component with rapid symptom relief. In both budesonide–formoterol and salmeterol–fluticasone, the corticosteroid addresses inflammation over days, not minutes. The fast relief in AIR therapy comes from the bronchodilator, not the steroid.

Clinical application for this patient

This patient used salbutamol 6–8 times per week, which indicates poor asthma control and overreliance on a SABA-only rescue strategy. Prescribing budesonide–formoterol as needed ensures that every reliever use also delivers an inhaled corticosteroid, addressing the underlying inflammation that contributes to symptom escalation. This approach is consistent with the anti-inflammatory reliever (AIR) strategy recommended in current guidelines to reduce severe exacerbation risk. [1]References (research sources)

- [1]Beta<sub>2</sub>-agonist and anti-inflammatory combination therapy for asthma rescue: a paradigm shift in asthma care.Research articleSkolnik N, Stieritz J, Akers J, Hudd T, Wright WL, Gilbert I, Yusufova N, Cook B, Robb E, Naddaf H. (2026) · DOI: 10.3389/fmed.2026.1826737

## 임상 시나리오

Budesonide–Formoterol as RelieverWhy fast-onset LABA matters in as-needed asthma therapy
The rapid-relief effect of budesonide–formoterol comes from formoterol, which begins bronchodilation within 1–3 minutes. This onset is comparable to salbutamol, allowing as-needed use for acute symptoms.

In contrast, salmeterol has a slow onset of 15–30 minutes or longer, making salmeterol–fluticasone unsuitable for quick relief even though both are long-acting beta2-agonists.

The inhaled corticosteroid component, whether budesonide or fluticasone, acts on airway inflammation over days, not minutes, so it does not contribute to rapid symptom relief.

CautionDo not instruct patients to use salmeterol–fluticasone for acute symptom relief; its slow onset delays bronchodilation and may lead to inadequate treatment of an asthma exacerbation.

## 핵심 개념

- **Formoterol** — A long-acting beta2-agonist with rapid onset of bronchodilation within 1–3 minutes, allowing as-needed reliever use in combination with an inhaled corticosteroid.
- **Salmeterol** — A long-acting beta2-agonist with slow onset of action, approximately 15–30 minutes or longer, making it unsuitable for acute symptom relief.
- **Inhaled corticosteroid** — An anti-inflammatory agent such as budesonide or fluticasone that acts on airway inflammation over days, not minutes.
- **Anti-inflammatory reliever therapy** — A guideline-based approach using a fast-onset LABA plus inhaled corticosteroid as needed for symptom relief and inflammation control.

## 같은 주제 문제

- [Situation: A 24-year-old woman with asthma is brought to the emergency room (ER) with whee…](https://mymerci.kr/pages/nclex_q.php?qn_id=629676)
- [Situation: A 24-year-old woman with asthma is brought to the emergency room (ER) with whee…](https://mymerci.kr/pages/nclex_q.php?qn_id=629677)
- [Situation: A 24-year-old woman with asthma is brought to the emergency room (ER) with whee…](https://mymerci.kr/pages/nclex_q.php?qn_id=629679)
- [Situation: A 36-year-old woman comes to the Rural Health Unit (RHU), which provides free t…](https://mymerci.kr/pages/nclex_q.php?qn_id=629680)
- [Situation: A 36-year-old woman comes to the Rural Health Unit (RHU), which provides free t…](https://mymerci.kr/pages/nclex_q.php?qn_id=629681)
- [Situation: A 36-year-old woman comes to the Rural Health Unit (RHU), which provides free t…](https://mymerci.kr/pages/nclex_q.php?qn_id=629682)
- [Situation: A 22-year-old tall, thin man who smokes is admitted to the surgical ward with a…](https://mymerci.kr/pages/nclex_q.php?qn_id=629683)
- [Situation: A 22-year-old tall, thin man who smokes is admitted to the surgical ward with a…](https://mymerci.kr/pages/nclex_q.php?qn_id=629684)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._